About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Short-term Effect of Rho-kinase Inhibitor on Retinal Circulation

NCT04234932·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Mary Jo Bilicek
CONTACT
210-805-3565 bilicek@uiwtx.edu

Lead

University of the Incarnate Word

Age

18–any

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Normal ocular health

You may not be if

Females who are or may be pregnant or who are nursing
Uncontrolled hypertension
Allergy to netarsudil or latanoprost

The record

StatusUnknown

PhaseEarly phase 1

Taking part10

StartedJan 2020

UpdatedApr 14, 2020

Conditions

Glaucoma, Open-Angle

Where1

University of the Incarnate Word
San Antonio, Texas, United States

Clareo Health | Short-term Effect of Rho-kinase Inhibitor on Retinal Circulation